Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.08.15.669078

White matter microstructure changes across the lifespan: a meta-analysis of longitudinal diffusion MRI studies

Colyer-Patel, K.·Teeuw, J.·Maes, V.·Goossens, V.·Brouwer, R. M.·Jahanshad, N.·Thompson, P. M.·Hulshoff Pol, H. E.
View original source ↗Export metadata ↓

Abstract

BackgroundWhite matter in the human brain is known to play a critical role in facilitating communication between different brain regions. White matter microstructure is often quantified using fractional anisotropy (FA) derived from diffusion-weighted MRI and is often considered a key measure of neural efficiency that is positively associated with motor and cognitive functioning. While lifespan trajectories of FA have been well studied in cross-sectional designs, it remains less clear how FA changes longitudinally with age across the lifespan, and whether the rates of change are influenced by genetic variation. MethodsWe systematically reviewed the evidence of white matter changes, as measured by fractional anisotropy (FA) with diffusion magnetic resonance imaging longitudinally across the lifespan, and the genetic influences on this change. Searches were conducted in Medline, PsycInfo, and EMBASE up to August 2023 with terms related to DTI/FA and longitudinal/change. Following this, genetic-related search terms were applied to the results, and the search was broadened to include other measures of white matter change. Our systematic search resulted in 29 studies that met our criteria. In addition, 14 studies investigated genetic influences on FA change rates across the lifespan. A meta-regression using a thin-plate spline model was conducted to examine annual whole-brain FA change as a function of age. ResultsAcross childhood and adolescence, FA increased, and the rate of increase slowed into early adulthood. Between ages 20 and 35, changes in FA were not statistically significant. This was followed by a significant decline in FA between ages 36 and 50. The decreases plateaued between ages 51 and 61 and then continued at a slightly slower rate towards the upper end of the age range assessed (77 years). Average FA change per year relative to baseline assessment reached a maximum of +1.1% during development, and-0.6% per year, during ageing. Significant heritability was found for change in local but not global FA during development. During ageing, common variants in genes that have been related to increased risk for neuropsychiatric disorders (APOE, HTT, MAPT) were associated in some studies with accelerated local FA decreases over time. ConclusionsIn conclusion, there are changes in white matter microstructure within individuals across the lifespan, with increases during childhood, adolescence and early adulthood, followed by a period of relative stability during early to mid-adulthood, and subsequent gradual declines from midlife onwards. Evidence is emerging for genetic influences on white matter changes over time, shaping individual trajectories.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Colyer-Patel, K., Teeuw, J., Maes, V., Goossens, V., Brouwer, R. M., Jahanshad, N., Thompson, P. M., Hulshoff Pol, H. E.. 2025-08-20. White matter microstructure changes across the lifespan: a meta-analysis of longitudinal diffusion MRI studies. https://doi.org/10.1101/2025.08.15.669078

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗